Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 954.65
-13.60 (-1.40%)
At close: Jan 23, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 153.37 billion as of January 23, 2026. Its market cap has decreased by -11.25% in one year.
Market Cap
153.37B
Enterprise Value
175.77B
Revenue
76.18B
Ranking
n/a
PE Ratio
32.19
Stock Price
954.65
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 153.37B, an increase of 37,607.39%. That is a compound annual growth rate of 26.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 153.37B | -9.91% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 384.52B |
| J. B. Chemicals & Pharmaceuticals | 294.79B |
| AstraZeneca Pharma India | 206.24B |
| Caplin Point Laboratories | 135.05B |
| Granules India | 134.12B |
| Rubicon Research | 109.37B |
| Sanofi India | 93.47B |
| Procter & Gamble Health | 90.41B |